201 related articles for article (PubMed ID: 28381184)
21. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
Liu C; Wang X; Genchev GZ; Lu H
Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
[TBL] [Abstract][Full Text] [Related]
22. Genomics of human glioblastoma multiforme: a glimpse of the future.
Komotar RJ; Syed ON; Bruce JN; Connolly ES; Dunn IF; Friedlander RM
Neurosurgery; 2008 Dec; 63(6):15. PubMed ID: 19057310
[No Abstract] [Full Text] [Related]
23. Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival.
Chiu YC; Wang LJ; Lu TP; Hsiao TH; Chuang EY; Chen Y
BMC Bioinformatics; 2017 Feb; 18(1):132. PubMed ID: 28241741
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
[TBL] [Abstract][Full Text] [Related]
25. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.
Yuan Y; Zhang H; Liu X; Lu Z; Li G; Lu M; Tao X
Oncotarget; 2017 Aug; 8(35):58386-58393. PubMed ID: 28938564
[TBL] [Abstract][Full Text] [Related]
27. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.
Kase M; Vardja M; Lipping A; Asser T; Jaal J
Radiother Oncol; 2011 Oct; 101(1):127-31. PubMed ID: 21775006
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients.
Oblinger JL; Pearl DK; Boardman CL; Saqr H; Prior TW; Scheithauer BW; Jenkins RB; Burger PC; Yates AJ
Neuropathol Appl Neurobiol; 2006 Aug; 32(4):410-8. PubMed ID: 16866986
[TBL] [Abstract][Full Text] [Related]
29. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
Khatri RG; Navaratne K; Weil RJ
J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
[TBL] [Abstract][Full Text] [Related]
30. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453
[TBL] [Abstract][Full Text] [Related]
31. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
Tanaka S; Akimoto J; Narita Y; Oka H; Tashiro T
J Neurosurg; 2014 Oct; 121(4):818-26. PubMed ID: 25105699
[TBL] [Abstract][Full Text] [Related]
32. Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme.
Seidlitz A; Siepmann T; Löck S; Juratli T; Baumann M; Krause M
Radiat Oncol; 2015 Aug; 10():172. PubMed ID: 26276734
[TBL] [Abstract][Full Text] [Related]
33. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
34. Age-specific signatures of glioblastoma at the genomic, genetic, and epigenetic levels.
Bozdag S; Li A; Riddick G; Kotliarov Y; Baysan M; Iwamoto FM; Cam MC; Kotliarova S; Fine HA
PLoS One; 2013; 8(4):e62982. PubMed ID: 23658659
[TBL] [Abstract][Full Text] [Related]
35. MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients.
Lakomy R; Sana J; Hankeova S; Fadrus P; Kren L; Lzicarova E; Svoboda M; Dolezelova H; Smrcka M; Vyzula R; Michalek J; Hajduch M; Slaby O
Cancer Sci; 2011 Dec; 102(12):2186-90. PubMed ID: 21895872
[TBL] [Abstract][Full Text] [Related]
36. Exploring the key genes and signaling transduction pathways related to the survival time of glioblastoma multiforme patients by a novel survival analysis model.
Xia Y; Yang C; Hu N; Yang Z; He X; Li T; Zhang L
BMC Genomics; 2017 Jan; 18(Suppl 1):950. PubMed ID: 28198665
[TBL] [Abstract][Full Text] [Related]
37. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
[TBL] [Abstract][Full Text] [Related]
38. Improve Glioblastoma Multiforme Prognosis Prediction by Using Feature Selection and Multiple Kernel Learning.
Zhang Y; Li A; Peng C; Wang M
IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(5):825-835. PubMed ID: 27071189
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.
Ermoian RP; Furniss CS; Lamborn KR; Basila D; Berger MS; Gottschalk AR; Nicholas MK; Stokoe D; Haas-Kogan DA
Clin Cancer Res; 2002 May; 8(5):1100-6. PubMed ID: 12006525
[TBL] [Abstract][Full Text] [Related]
40. Identification of prognostic signature in cancer based on DNA methylation interaction network.
Hu WL; Zhou XH
BMC Med Genomics; 2017 Dec; 10(Suppl 4):63. PubMed ID: 29322932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
